Kezar Life Sciences, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Kauffman Michael | — | C | 10,516 | — | — | 63,690 | Jun 25, 2018 |
| BERGER FRANKLIN M | — | Purchase | 50,000 | $15.00 | $750,000 | 563,157 | Jun 25, 2018 |
| Aberdare Management Company, LLC | — | C | 105,162 | — | — | 105,162 | Jun 25, 2018 |
| Chiesi Giacomo | — | C | 314,819 | — | — | 314,819 | Jun 25, 2018 |
| A.M. Pappas Life Science Ventures V, LP | — | C | 23,894 | — | — | 23,894 | Jun 25, 2018 |
| AMGEN INC | — | C | 1,121,384 | — | — | 1,121,384 | Jun 25, 2018 |
| Lim Richard J. | — | C | 377,783 | — | — | 693,272 | Jun 25, 2018 |